Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FN3UB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,361
Award facts
- Contract value 100% obligated
- $22,360.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,360.69 to AmerisourceBergen Drug Corp for the supply of Wegovy 1.7 mg/0.75 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement that extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of pharmaceuticals and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards demonstrate significant capability in fulfilling medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This Wegovy delivery order exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare needs through the DLA's Pharmaceutical Prime Vendor program.
Quick answers
Who was awarded contract SPE2DB25FN3UB?
SPE2DB25FN3UB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FN3UB worth?
The government has obligated $22,361 on SPE2DB25FN3UB.
Is contract SPE2DB25FN3UB an order under another contract?
Yes. SPE2DB25FN3UB is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3UB competed?
The extent of competition for SPE2DB25FN3UB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award